Zepp Health (ZEPP) Stock Price, News & Analysis

Company Overview

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

Key Stats

• Today's Range: $36.35 to $39.45
• 50-Day Range: $2.39 to $43.17
• 52-Week Range: $2.13 to $45.45
• Volume: 203,056 shs
• Average Volume: 666,853 shs
• Market Capitalization: $544.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $60.23
• Consensus Rating: Buy

Zepp Health Stock Analysis - MarketRank™

Zepp Health scored higher than 53% of companies evaluated by MarketBeat, and ranked 530th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Zepp Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Zepp Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Zepp Health is -7.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Zepp Health is -7.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Zepp Health has a P/B Ratio of 2.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.72% of the float of Zepp Health has been sold short.

Short Interest Ratio / Days to Cover

Zepp Health has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Zepp Health has recently increased by 7.71%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zepp Health does not currently pay a dividend.

Dividend Growth

Zepp Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.72% of the float of Zepp Health has been sold short.

Short Interest Ratio / Days to Cover

Zepp Health has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Zepp Health has recently increased by 7.71%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.67

News Sentiment

Zepp Health has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Zepp Health this week, compared to 1 article on an average week.

Search Interest

Only 4 people have searched for ZEPP on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.

MarketBeat Follows

5 people have added Zepp Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Zepp Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ZEPP Stock Analysis - Frequently Asked Questions

How have ZEPP shares performed this year?

Zepp Health's stock was trading at $2.60 at the beginning of the year. Since then, ZEPP stock has increased by 1,343.7% and is now trading at $37.5360.

How were Zepp Health's earnings last quarter?

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) announced its quarterly earnings data on Monday, May, 19th. The company reported ($1.13) earnings per share for the quarter. The company earned $38.54 million during the quarter. Zepp Health had a negative net margin of 38.81% and a negative trailing twelve-month return on equity of 24.19%.
Read the conference call transcript.

When did Zepp Health's stock split?

Zepp Health's stock reverse split on the morning of Monday, September 16th 2024.The 1-4 reverse split was announced on Friday, September 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Who are Zepp Health's major shareholders?

Zepp Health's top institutional shareholders include Allspring Global Investments Holdings LLC (4.21%) and Group One Trading LLC.

How do I buy shares of Zepp Health?

Shares of ZEPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Zepp Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Zepp Health investors own include Nextera Energy Partners (NEP), NVIDIA (NVDA), PayPal (PYPL), Arista Networks (ANET), MercadoLibre (MELI), ASML (ASML).

Company Calendar

• Last Earnings: 5/19/2025
• Today: 8/29/2025
• Next Earnings (Estimated): 11/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Computer Hardware
• Current Symbol: NYSE:ZEPP
• CIK: 1720446
• Web: www.huami.com
• Phone: 861059403268
• Fax: N/A
• Employees: 1,230
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Zepp Health: $60.23
• High Price Target: $60.23
• Low Price Target: $60.23
• Potential Upside/Downside: +60.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($4.83)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$75.73 million
• Net Margins: -38.81%
• Pretax Margin: -29.77%
• Return on Equity: -24.19%
• Return on Assets: -11.36%

Debt

• Debt-to-Equity Ratio: 0.31
• Current Ratio: 1.10
• Quick Ratio: 0.78

Sales & Book Value

• Annual Sales: $182.60 million
• Price / Sales: 2.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $15.55 per share
• Price / Book: 2.41

Miscellaneous

• Outstanding Shares: 14,500,000
• Free Float: 9,279,000
• Market Cap: $544.27 million
• Optionable: Optionable
• Beta: 1.11